Injectable Drug Delivery Devices Market Demand and Supply by 2023; Based on Type and Application

The Global Injectable Drug Delivery Devices Market is expected to grow at a CAGR of 11.8% during forecasted period 2017-2023.

The injectable drug delivery devices are used to deliver the medication into the blood stream. The injectable drug delivery devices market is estimated to grow at a CAGR of 11.8% owning to increasing prevalence of cancer and diabetes. According to WHO, The number of people with diabetes had risen to 422 million in 2014 , 14.1 million cancer cases was registered around the world in 2012 and this  is expected to increase up to 24 million by 2035. Increasing prevalence of other chronic diseases, technological advances and many advantages of the injectable drug delivery method has uplifted the growth of the market. However, availability of alternative delivery devices and high risk of blood-borne infections have restrained the growth of the market.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/1211 .

Competitive Analysis

The major key player for the global injectable drug delivery devices market are Becton, Dickinson and Company (US), Baxter International (US), Schott AG (Germany), Eli Lilly and Company (US), Pfizer (US), Gerresheimer AG (Germany), Terumo Corporation (Japan), Antares Pharma, Inc. (US), Novo Nordik (Denmark), Sanofi SA (France), Unilife Corporation (US), Zogenix, Inc (US), Hospira, Inc (US), Presage Bioscience (US), MicroCHIPS, Inc (US), Pearl Therapeutics Inc (US), Genentech Inc. (US), Bend Research (US)

Becton, Dickinson and Company is an America multination company headquartered in New Jersey. 60% of company sales were generated from non-U.S. markets. As company is trying to develop their market in other countries. Company has launched a number of products like insulin pen and other injectable needles. HyFlow is the self-injection with thin wall needle used in the delivery of highly viscous drug formulations. Physioject, Libertas, Intevia are some of the auto injector manufactured by the company. There is 4% grow in the company’s market in 2016.

Eli Lilly and Company is an US headquartered. Company is focusing on development of new innovation center with a focus on drug delivery devices. It is expected to double its revenues from device-enabled products by 2020.

Check Discount @ https://www.marketresearchfuture.com/check-discount/1211 .

Global injectable drug delivery devices market is saturated by the presence of a number of small and medium sized companies. Some of them are focusing on the development of new products for the treatment, while some of leading companies in this market are collaborating with local companies in order to minimize the competition and increase the product range

Brief TOC

1. Introduction   
2. Research Methodology              
3. Market Dynamics          
4. Market Factor Analysis             
5. Global Injectable Drug Delivery Devices, By Route Of Administration
6. Global Injectable Drug Delivery Devices, By Devices
7. Global Injectable Drug Delivery Devices, By Utility
8. Global Injectable Drug Delivery Devices, By End Users
9. Global Injectable Drug Delivery Devices, By Region    
10. Competitive Landscape
11. Company Profile            
12. Conclusion
13. Appendix

Ask to Expert @ https://www.marketresearchfuture.com/enquiry/1211 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand,

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com